Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio
Business Exposures
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Hims Stock Crashes After FDA Resolves Weight-Loss Drugs Shortage
Via Investor's Business Daily
Exposures Product Safety
Tickers HIMS LLY NVO
Elon Musk's Tesla Recalls Nearly 380,000 Model 3, Y Vehicles In US Over Loss Of Power Steering Assist Concerns
Via Benzinga
Topics Product Recall
Exposures Legal Product Safety
Tickers TSLA
AirAllergen Reinforces Commitment to Customer Service and Education in Indoor Air Quality
Via Press Advantage
Topics Product Recall
Exposures Legal Product Safety
iQure Pharma, Zefit’s Partner, Secures FDA Orphan Drug Designation for Dravet Syndrome Treatment
Via AB Newswire
Exposures Product Safety
International Process Solutions Offers Onsite Temperature Calibration Services
Via AB Newswire
Exposures Product Safety
Roger B. Bagwell, Ph.D., is named the Actuated Medical Director, Neural Device Operations
Via PRLog
Topics Intellectual Property
Exposures Intellectual Property Product Safety
ImmunityBio Surges On FDA Green Light For Expanded Bladder Cancer Vaccine Access — Retail Buzz Intensifies
Via Stocktwits
Exposures Product Safety
Tickers IBRX MRK
Harmony Biosciences Stock Falls On FDA Setback For Pitolisant In Sleeping Disorder
Via Benzinga
Exposures Product Safety
Tickers HRMY
Medcrypt Unveils Enhanced Helm SBOM Vulnerability Management Tool: The First Industry-Specific Solution for Medical Device Manufacturers
Via PRUnderground
Exposures Product Safety
Solid Biosciences Soars 32% on Trial Data: 189% Upside from Here?
Via MarketBeat
Exposures Product Safety
Tickers SLDB SRPT
Moderna: A Generational Opportunity for Investors in 2025
Via MarketBeat
Exposures COVID-19 Product Safety
Tickers MRNA
DOGE Reportedly Fires FDA Staff Reviewing Elon Musk's Neuralink: 'We Should Be Worried About The Whole Trial,' Says Former Official
Via Benzinga
Exposures Product Safety
Tickers TSLA
BioMedNewsBreaks — CNS Pharmaceuticals Inc. (NASDAQ: CNSP) to Present at 6th Glioblastoma Drug Development Summit
Via Investor Brand Network
Exposures Product Safety
Tickers CNSP
Axsome's AXS-05 In Alzheimer's Agitation Could Be Billion Dollar Opportunity, Says Analyst
Via Benzinga
Exposures Product Safety
Tickers AXSM ITCI JNJ
InvestorNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Files Provisional Patent for SPC-15 Dual-Action Treatment
Via Investor Brand Network
Topics Intellectual Property
Exposures Intellectual Property Product Safety
Tickers SILO
Final APLT Deadline Reminder: February 18, 2025 Filing Deadline in Securities Class Action - Contact Kessler Topaz Meltzer & Check, LLP
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal Product Safety
Tickers APLT
Final APLT Deadline Reminder: February 18, 2025 Filing Deadline in Securities Class Action - Contact Kessler Topaz Meltzer &amp; Check, LLP
Via TheNewswire.com
Topics Lawsuit
Exposures Financial Legal Product Safety
Tickers APLT
FDA Approves GSK's 5-in-1 Meningococcal Vaccine For Adolescents Ahead Of CDC Advisory Committee Vote Meeting Next Week
Via Benzinga
Exposures Product Safety
Tickers GSK
FDA Approves Sanofi's Merilog As First Rapid-Acting Insulin Biosimilar Product For Diabetes
Via Benzinga
Exposures Product Safety
Tickers LLY NVO SNY
APLT Deadline in 1 Day: Kessler Topaz Meltzer & Check, LLP Reminds Applied Therapeutics, Inc. (APLT) Investors of Filing Deadline in Class Action Lawsuit
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal Product Safety
Tickers APLT
APLT Deadline in 1 Day: Kessler Topaz Meltzer &amp; Check, LLP Reminds Applied Therapeutics, Inc. (APLT) Investors of Filing Deadline in Class Action Lawsuit
Via TheNewswire.com
Topics Lawsuit
Exposures Financial Legal Product Safety
Tickers APLT
DEADLINE TOMORROW: Kaplan Fox Reminds Investors of a Deadline for a Securities Class Action Lawsuit Against Applied Therapeutics (APLT)
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal Product Safety
Tickers APLT
DEADLINE TOMORROW: Kaplan Fox Reminds Investors of a Deadline for a Securities Class Action Lawsuit Against Applied Therapeutics (APLT)
Via TheNewswire.com
Topics Lawsuit
Exposures Financial Legal Product Safety
Tickers APLT
Kaplan Fox Reminds Investors of a Deadline for a Securities Fraud Class Action Lawsuit Against Applied Therapeutics (APLT)
Via TheNewswire.com
Topics Fraud Lawsuit
Exposures Financial Legal Product Safety
Tickers APLT
Kaplan Fox Reminds Investors of a Deadline for a Securities Fraud Class Action Lawsuit Against Applied Therapeutics (APLT)
Via NewMediaWire
Topics Fraud Lawsuit
Exposures Financial Legal Product Safety
Tickers APLT
AstraZeneca's Imfinzi Perioperative Regimen Shows Improved Survival Outcomes In Bladder Cancer Patients
Via Benzinga
Exposures Product Safety
Tickers AZN
Small-Cap OS Therapies Inks Commercial Manufacture Agreements For Lead Cancer Drug For Rare Type Of Bone Cancer
Via Benzinga
Exposures Product Safety
Tickers OSTX
ISO-CERT International Certification Office Expands Services for ISO, FDA, and CE Marking
Via Get News
Exposures Product Safety
Kaplan Fox Alerts Investors to a Deadline for a Securities Fraud Class Action Lawsuit Against Applied Therapeutics (APLT)
Via NewMediaWire
Topics Fraud Lawsuit
Exposures Financial Legal Product Safety
Tickers APLT
Kaplan Fox Alerts Investors to a Deadline for a Securities Fraud Class Action Lawsuit Against Applied Therapeutics (APLT)
Via TheNewswire.com
Topics Fraud Lawsuit
Exposures Financial Legal Product Safety
Tickers APLT
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.